Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blood substitutes based on nanobiotechnology.

Thomas Ming Swi Chang1

  • 1Department of Physiology, Faculty of Medicine, McGill University, 3655 Drummond Street, Montreal, Quebec, H3G 1Y6, Canada. artcell.med@mcgill.ca

Trends in Biotechnology
|July 4, 2006
PubMed
Summary

Concerns about blood safety drive the development of blood substitutes. Nanobiotechnology offers promising new approaches, with some already in clinical trials, advancing the next generation of these vital medical innovations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial Cells: Perspective on Reconstructing Biological Cells and "Out of the Box" Innovations.

Chembiochem : a European journal of chemical biology·2026
Same author

Intracellular Targeted Nanocapsules Containing Nanobiotherapeutic Suppress Lung, Liver, Breast and Cervix Cancer Cell Lines by Prodrug Activation or Removal of Intracellular Tyrosine.

Cancers·2025
Same author

Biodegradable Polylactide Nanocapsules Containing Quercetin for In Vitro Suppression of Mouse B16F10 and Human Sk-Mel-28 Melanoma Cell Lines.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Superparamagnetic polyhemoglobin-tyrosinase nanocapsules: a novel biotherapeutic with enhanced tumor suppression with control by external magnetic field.

Frontiers in bioengineering and biotechnology·2025
Same author

Superparamagnetic Artificial Cells PLGA-Fe<sub>3</sub>O<sub>4</sub> Micro/Nanocapsules for Cancer Targeted Delivery.

Cancers·2023
Same author

Editorial: Innovative medical technology based on artificial cells, including its different configurations.

Frontiers in medical technology·2023

Area of Science:

  • Biotechnology
  • Nanotechnology
  • Medical Science

Background:

  • Concerns regarding infective agents in donated blood have spurred research into blood substitutes since the early 1900s.
  • Significant advancements in biotechnology and nanotechnology have led to promising developments in this field.

Purpose of the Study:

  • To review current nanobiotechnological approaches for blood substitute development.
  • To discuss the application of fundamental knowledge in creating next-generation blood substitutes.

Main Methods:

  • Review of nanobiotechnological strategies currently in phase III clinical trials.
  • Analysis of foundational scientific knowledge contributing to new blood substitute designs.

Main Results:

Related Experiment Videos

  • Several nanobiotechnological approaches are demonstrating significant promise in late-stage clinical trials.
  • The integration of basic scientific insights is crucial for advancing blood substitute technology.

Conclusions:

  • Nanobiotechnology is a key enabler for the development of effective and safe blood substitutes.
  • Continued research and development are essential for realizing the full potential of next-generation blood substitutes.